Documentation of Right-Ear Otitis Externa
For a right-ear otitis externa encounter, document rapid-onset ear pain with tragal tenderness, perform aural toilet before prescribing topical fluoroquinolone drops, and provide appropriate analgesia with reassessment in 48–72 hours.
Chief Complaint
- Document the primary symptom: "Right ear pain" with onset timing (typically <48 hours for acute otitis externa) 1
- Record associated symptoms: itching, fullness, hearing changes, or discharge 1
- Note any water exposure (swimming, showering) or recent ear canal trauma (cotton swabs, hearing aids) 1
History of Present Illness
Symptom Characteristics
- Pain quality and severity: Describe as sharp, throbbing, or constant; rate severity on 0–10 scale 1
- Timing: Rapid onset within 48 hours is characteristic 1
- Aggravating factors: Pain with tragus/pinna manipulation, chewing, or lying on affected side 2
- Associated symptoms: Pruritus, aural fullness, hearing reduction, or otorrhea 1, 3
Precipitating Events
- Recent swimming or water exposure 4, 3
- Ear canal manipulation (cotton swabs, fingernails, hearing aids) 4
- Recent upper respiratory infection 1
- Use of ear plugs or hearing aids 2
Past Medical History
Critical Risk Factors to Document
- Diabetes mellitus (including glycemic control status) – increases risk of necrotizing otitis externa and otomycosis 1, 5, 6
- Immunocompromised state (HIV, transplant recipient, chemotherapy, chronic steroid use) 1, 6, 7
- Prior ear surgery or tympanostomy tubes 1, 5
- History of radiation therapy to head/neck 1, 5, 7
- Dermatologic conditions (eczema, psoriasis, seborrheic dermatitis) affecting the ear 2, 3
- Previous episodes of otitis externa (frequency and treatment response) 4, 3
Medications
- List all current medications, particularly:
Allergies
- Neomycin allergy – critical because neomycin causes contact sensitivity in 13–30% of patients with chronic otitis externa 1
- Other topical antibiotic allergies (polymyxin B, bacitracin) 1
- Fluoroquinolone allergy 1
- Hydrocortisone or other steroid allergies 1
Review of Systems
Ear-Specific
- Otalgia (right ear) 1, 3
- Otorrhea (describe color, consistency) 1, 3
- Pruritus 1, 3
- Hearing loss or aural fullness 1, 3
- Tinnitus 3
Red Flags Requiring Immediate Attention
- Facial weakness or paralysis (cranial nerve VII involvement) 2, 6
- Severe headache 6
- Fever 6
- Periauricular swelling or cellulitis 1, 5
- Neurologic deficits 6
- Pain out of proportion to examination findings 6
Physical Examination
Inspection
- External ear: Erythema, edema, or lesions of pinna 1, 3
- Periauricular area: Swelling, erythema, or lymphadenopathy 1
Palpation
- Tragal tenderness: Apply gentle pressure to tragus – intense tenderness is pathognomonic for otitis externa 1, 3
- Pinna manipulation: Pull pinna superiorly and posteriorly – pain indicates external canal involvement 1, 3
- Periauricular lymph nodes: Document presence, size, and tenderness 1
Otoscopy
- Canal findings: Erythema, edema (grade severity), debris, cerumen, or discharge 1, 3
- Tympanic membrane status: Intact vs. perforated, mobility (pneumatic otoscopy when possible), presence of tympanostomy tubes 1, 5
- Visualization: Document if TM fully visible or obscured by edema/debris 1, 5
- Granulation tissue: Presence suggests possible necrotizing otitis externa in high-risk patients 6
Neurologic Examination (in high-risk patients)
- Cranial nerve function, especially facial nerve (CN VII) 6
Assessment
Primary Diagnosis
Modifying Factors (Document if Present)
- Intact vs. non-intact tympanic membrane 1, 5
- Presence of tympanostomy tubes 1, 5
- Diabetes mellitus or immunocompromised state 1, 5, 6
- Prior ear surgery or radiation 1, 5
- Severe canal edema preventing drop entry 1, 5
Differential Diagnoses to Exclude
- Necrotizing (malignant) otitis externa – suspect in diabetic/immunocompromised patients with severe pain, granulation tissue, or cranial nerve involvement 6
- Chronic suppurative otitis media – painless otorrhea through TM perforation without tragal tenderness 1
- Acute otitis media with perforation 1
- Contact dermatitis – from topical agents, especially neomycin 2, 1
- Fungal otitis externa (otomycosis) – white fuzzy exudate with pruritus 1
- Furunculosis – localized pustular lesion in outer third of canal 2
- Herpes zoster oticus – vesicles with facial paralysis 2
Management Plan
1. Aural Toilet (Essential First Step)
- Remove debris, cerumen, and inflammatory material before any medication to ensure drops reach infected tissue 1, 5
- Method selection:
2. Wick Placement (If Indicated)
- Place compressed cellulose wick if severe canal edema prevents drop entry or TM cannot be visualized 1, 5
- Instruct patient to apply drops to wick; remove wick after 24–48 hours when edema subsides 1
3. Topical Antimicrobial Therapy (First-Line)
When Tympanic Membrane Status Is Uncertain or Compromised
- Prescribe non-ototoxic fluoroquinolone drops only 1, 5:
- Avoid aminoglycoside-containing preparations (neomycin/polymyxin B) due to ototoxicity risk 1, 5
When Tympanic Membrane Is Intact
Drop Administration Instructions
- Warm bottle in hands for 1–2 minutes 1
- Lie with affected ear upward 1, 5
- Fill ear canal completely with drops 1, 5
- Remain in position for 3–5 minutes (use timer) 1, 5
- Apply gentle tragal pumping or pinna movement to eliminate trapped air 1, 5
- Have another person administer drops if possible (improves adherence) 1
Treatment Duration
- Minimum 7 days, even if symptoms resolve earlier (prevents relapse) 1, 5
- If symptoms persist beyond 7 days, continue until resolution (maximum 14 days total) 1
4. Pain Management
Mild-to-Moderate Pain
Severe Pain
- Short-term opioid-containing analgesics for first 48–72 hours 1, 5
- Reassure patient that pain typically improves within 48–72 hours of starting topical therapy 1, 5
Avoid
- Do not prescribe topical anesthetic drops (benzocaine) – not FDA-approved for active infection and may mask treatment failure 1
5. Systemic Antibiotics (Reserved Indications Only)
Oral antibiotics are NOT indicated for uncomplicated otitis externa 1, 5
Prescribe Systemic Antibiotics Only When:
- Infection extends beyond ear canal (periauricular cellulitis/swelling) 1, 5
- Patient has diabetes mellitus or immunocompromised state 1, 5, 6
- Severe canal edema prevents adequate topical delivery despite wick placement 1, 5
- No improvement after 48–72 hours of appropriate topical therapy 1, 5
Recommended Systemic Agent
- Ciprofloxacin 500 mg PO twice daily for 7–10 days (covers Pseudomonas aeruginosa and Staphylococcus aureus, which cause ~98% of cases) 1
6. Activity Restrictions and Patient Education
- Keep ear dry during treatment – cover canal with earplug or petroleum jelly-coated cotton before showering 1, 5
- Avoid swimming until infection resolves 1, 5
- Do not insert cotton swabs or any objects into ear canal 1, 5
- Complete full 7-day course even if symptoms improve 1, 5
- If patient tastes drops, notify physician immediately (indicates TM perforation) 1
7. Follow-Up and Reassessment
Common Causes of Treatment Failure
- Inadequate drug delivery (canal obstruction, poor adherence) 1
- Allergic contact dermatitis from topical agents (especially neomycin or hydrocortisone) 2, 1
- Fungal co-infection (otomycosis) 1, 5
- Incorrect diagnosis (chronic suppurative otitis media, necrotizing otitis externa) 1, 6
8. Special Considerations for High-Risk Patients
Diabetic or Immunocompromised Patients
- Monitor closely for necrotizing otitis externa (severe pain, granulation tissue, cranial nerve involvement) 1, 6
- Avoid ear canal irrigation – use atraumatic suction only 1, 5
- Consider systemic antibiotics even for seemingly uncomplicated cases 1, 5
- Lower threshold for ENT referral 6
Suspected Fungal Infection (Otomycosis)
- White fuzzy exudate with pruritus suggests Aspergillus 1
- Treatment: Thorough debridement + topical antifungal (clotrimazole 1% or boric acid 2%) 3–4 times daily for 7–10 days 1
- Avoid antibacterial drops that promote fungal overgrowth 1, 5
Common Pitfalls to Avoid
- Prescribing oral antibiotics for uncomplicated cases (occurs in 20–40% of patients inappropriately) 1
- Using ototoxic preparations when TM integrity is uncertain 1, 5
- Skipping aural toilet before drop administration 1, 5
- Inadequate pain management 1, 5
- Irrigating ear canal in diabetic/immunocompromised patients 1, 5
- Missing fungal infections in high-risk patients 1, 5
- Prescribing neomycin-containing drops to patients with eczema or contact dermatitis history 1